EX-23.1 6 d586634dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-189217) of Enanta Pharmaceuticals, Inc. of our report dated December 18, 2013 relating to the financial statements, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
December 18, 2013